ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 52 of 59
УЖМБС 2020, 5(5): 386–393
Physical training and Sport. Medical and biological aspects of training athletes

Physiological and Hereditary Hyperbilirubinemia in Athletes: Role in Reducing Efficiency and Correction Methodology

Gunina L. M. 1, Mylashyus Kazys 2, Voitenko V. L. 3

Under high-intensity loads, the athlete's bodies take place a number of biochemical reactions and physiological processes that can lead to hyperbilirubinemia. The factors that can initiate the onset of this phenomenon include the syndrome of micro-damage muscle, violation of the integrity of erythrocyte membranes, decreased blood pH, malnutrition and increase oxygen demand of the body. Degree of expression of manifestations of physiological bilirubinemia depends on the level of adaptation of the athlete to the physical activities offered. Hyperbilirubinemia in athletes can be one of the components of the deterioration of the functional state, forming the symptoms of endogenous intoxication. The relevance of this problem in sport lies in the relatively low detection rate of hyperbilirubinemia due to the lack of regular screening studies. However, in drawing up a plan of nutritional- metabolic support for training and competitive activity and recovery measures, must not only the individual reaction of the athlete body to physical activity, but also the severity of shifts in the indicators of bilirubin metabolism and their ratio. The article describes the reasons for the increase in bilirubin levels, which can be caused by both the effect of physical activity and by the presence of pathological processes in athletes. The factors influencing the blood serum’s bilirubin content are also highlighted, which include the state of erythrocyte cell membranes and the rate of hemoglobin destruction, the functional state of the liver, the specifics of physical loads and the use of ergogenic pharmacological agents by athletes. Particular accent has been placed on the illumination of hereditary hyperbilirubinemias, which may have been detected at the stage of selection of athletes. The most common phenomenon is Gilbert's syndrome, which occurs in 2-5% of cases in the general population, is characterized in the clinic by a benign flow and is manifested by episodes of jaundice and an increase in total bilirubin content to moderate values due to indirect. The frequency of detection of hyperbilirubinemias in the population of athletes is 4.68%, among which Gilbert's disease accounts for almost half (48.7%). Conclusion. The work highlighted the pathogenesis and diagnostic algorithm of Gilbert's disease, and also emphasized that its drug prevention and correction in athletes to maintain functional and physical fitness should be carried out taking into account anti-doping rules, which requires upon diagnosis timely receipt of a therapeutic exclusion

Keywords: bilirubin, hereditary hyperbilirubinemias, Gilbert's disease, hemolysis of erythrocytes, physical performance, laboratory diagnostics

Full text: PDF (Ua) 359K

  1. Mougios V. Exercise biochemistry. Champaign, Illinois, USA: Human Kinetics; 2006. 296 р.
  2. Nikulin BA, Rodionova II. Biochemical control in sports. M: Sovetskij sport; 2011. 232 р. [Russian]
  3. Banfi G, Colombini A, Lombardi G, Lubkowska A. Metabolic markers in sports medicine. Adv Clin Chem. 2012; 56: 1-54.
  4. Dmitriev A, Gunina L. Syndromes of micro-muscle injury and delayed muscle soreness in elite sports: role in the development of fatigue and prevention. Nauka v olimpijskom sporte. 2020; 1: 57-71. [Russian]
  5. Lee EC, Fragala MS, Kavouras SA, Queen RM, Pryor JL, Casa DJ. Biomarkers in Sports and Exercise: Tracking Health, Performance, and Recovery in Athletes. J Strength Cond Res. 2017; 31(10): 2920-2937.
  6. Lang E, Gatidis S, Freise NF, Bock H, Kubitz R, Lauermann C, et al. Conjugated bilirubin triggers anemia by inducing erythrocyte death. Hepatology. 2015; 61(1): 275-284.
  7. Barcellini W, Fattizzo B. Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia. Dis Markers. 2015; 2015: 635670.
  8. Phillips J, Henderson AC. Hemolytic Anemia: Evaluation and Differential Diagnosis. Am Fam Physician. 2018; 98(6): 354-361. PMID: 30215915
  9. Tang M, Armstrong CL, Leidy HJ, Campbell WW. Normal vs. high-protein weight loss diets in men: effects on body composition and indices of metabolic syndrome. Obesity (Silver Spring). 2013; 21(3): E204−210.
  10. Piperno A, Bertola F, Bentivegna A. Juvenile Hemochromatosis. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, et al, Eds. Gene Reviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2020. 2005, Feb 17. PMID: 20301349
  11. Bazulco AS. Biochemical basis of sports muscular activity. Minsk BGUPgC; 2006. 85 p. [Russian]
  12. Anđelković M, Baralić I, Đorđević B, Stevuljević KJ, Radivojević N, Dikić N, et al. Hematological and Biochemical Parameters in Elite Soccer Players During A Competitive Half Season. J Med Biochem. 2015; 34(4): 460-466.
  13. Solomonov AV, Shipitsyna MK, Vashurin AS, Rumyantsev EV, Timin AS, Ivanov SP. Analysis of binding ability of two tetramethylpyridylporphyrins to albumin and its complex with bilirubin. Spectrochim Acta A Mol Biomol Spectrosc. 2016; 168: 12-20.
  14. Kapitonova AN, Kruglova IV, Chadina AB. Hyperbilirubinemia in elite sports. Sovremennye voprosy biomedicziny. 2018; 2(4/5): 16-22.
  15. Klainbart S, Grabernik M, Kelmer E, Chai O, Cuneah O, Segev G, et al. Clinical manifestations, laboratory findings, treatment and outcome of acute organophosphate or carbamate intoxication in 102 dogs: A retrospective study. Vet J. 2019; 251: 105349.
  16. Karabacak M, Kanbur M, Eraslan G, Siliğ Y, Soyer Sarıca Z, Tekeli MY, et al. The effects of colostrum on some biochemical parameters in the experimental intoxication of rats with paracetamol. Environ Sci Pollut Res Int. 2018; 25(24): 23897-23908.
  17. Sedlak TW, Saleh M, Higginson DS, Paul BD, Juluri KR, Snyder SH. Bilirubin and glutathione have complementary antioxidant and cytoprotective roles. Proc Nat Acad Sci USA. 2009; 106(13): 5171-5176.
  18. Fujiwara R, Haag M, Schaeffeler E, Nies AT, Zanger UM, Schwab M. Systemic regulation of bilirubin homeostasis: Potential benefits of hyperbilirubinemia. Hepatology. 2018; 67(4): 1609-1619.
  19. Witek K, Ścisłowska J, Turowski D, Lerczak K, Lewandowska -Pachecka S, Pokrywka A. Total bilirubin in athletes, determination of reference range. Biol Sport. 2017; 34(1): 45-48.
  20. Mercer KW, Densmore JJ. Hematologic disorders in the athlete. Clinics in Sports Medicine. 2005; 24(3): 599-621.
  21. Alkhunaizi AM, El Tigani MA, Rabah RS, Nasr SH. Acute bile nephropathy secondary to anabolic steroids. Clin Nephrol. 2016; 85(2): 121-126.
  22. Miller BJ, Pate RR, Burgess W. Foot impact force and intravascular hemolysis during 
distance running. Int J Sports Med. 1988; 9: 56-60.
  23. Floreani A, Corsi N, Martines D, Varnier M, Naccarato R. No effect of endurance exercise on serum bilirubin in healthy athletes and with congenital hyperbilirubinemia (Gilbert's syndrome). J Sports Med Phys Fitness. 1993; 33(1): 79-82. PMID: 8350612
  24. Titsa NU. Clinical guidelines for laboratory tests. M: YuNIMED-press; 2003. 960 p. [Russian]
  25. Strassburg CP. Hyperbilirubinemia syndromes (Gilbert-Meulengracht, Crigler-Najjar, Dubin-Johnson, and Rotor syndrome). Best Pract Res Clin Gastroenterol. 2010; 24(5): 555-571.
  26. Wagner KH, Shiels RG, Lang CA, Seyed Khoei N, Bulmer AC. Diagnostic criteria and contributors to Gilbert's syndrome. Crit Rev Clin Lab Sci. 2018; 55(2): 129-139.
  27. Kadakol A, Ghosh SS, Sappal BS, Sharma G, Chowdhury JR, Chowdhury NR. Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype. Hum Mutat. 2000; 16(4): 297-306.
  28. Maruo Y, Nakahara S, Yanagi T, Nomura A, Mimura Y. Genotype of UGT1A1 and phenotype correlation between Crigler-Najjar syndrome type II and Gilbert syndrome. J Gastroenterol Hepatol. 2016; 31(2): 403-408.
  29. Bykhanov AV. Hereditary hyperbilirubinemia. Problemy sovremennoj medicziny: aktualnye voprosy; sbornik nauchny`kh trudov po itogam mezhdunarodnoj nauchno-prakticheskoj konferenczii. Krasnoyarsk; 2016. p. 57-61. [Russian]
  30. Alekseev NY, Sudakov OV, Sviridova TN, Fursova EA, Shanin PV. Modern aspects of the diagnosis of fulminant hepatic failure. Sistemnyj analiz i upravlenie v biomediczinskikh sistemakh. 2014; 13(4): 878−880. [Russian]
  31. Deshin RG. A short guide to pharmacological drugs allowed and prohibited in sports. 6th ed. Revised and enlarged. Ezhegodnyj sbornik. SPb: Gippokrat; 2019. 67 р. [Russian]
  32. Makarova GA, Kholyavko YA, Verlina GV. Clinical and laboratory examination of highly qualified athletes: the main directions of improvement. Lechebnaya fizkultura i sportivnaya mediczina. 2013; 7(115): 4-12. [Russian]
  33. Voitenko VL, Kuzmenko MV, Gunina LM, Oleshko VG. Correction of energy supply processes and prevention of oxidative stress during physical activity with the help of succinic acid derivatives. Materiali V Vseukrayinskoyi naukovoyi konferencziyi studentiv ta molodikh vchenikh z fiziologiyi z mizhnarodnoyu uchastyu «Fiziologiya – mediczini, farmacziyi ta pedagogiczi: Aktualni problemi ta suchasni dosyagnennya». Kharkiv; 2018. 2018: 135-137. (Ukrainiаn)
  34. Van Remoortel H, De Buck E, Compernolle V, Deldicque L, Vandekerckhove P. The effect of a standard whole blood donation on oxygen uptake and exercise capacity: a systematic review and meta-analysis. Transfusion. 2017; 57(2): 451-462.